Aquatic Capital Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.27M Buy
39,535
+29,080
+278% +$1.08M 0.04% 508
2025
Q4
$440K Buy
+10,455
New +$421K 0.01% 775
2024
Q4
Sell
-38,800
Closed -$1.32M 1634
2024
Q3
$1.32M Buy
38,800
+17,500
+82% +$492K 0.03% 447
2024
Q2
$462K Buy
21,300
+16,800
+373% +$353K 0.02% 556
2024
Q1
$99.7K Buy
4,500
+1,600
+55% +$39K ﹤0.01% 914
2023
Q4
$80K Sell
2,900
-5,000
-63% -$121K ﹤0.01% 1051
2023
Q3
$176K Buy
7,900
+7,400
+1,480% +$190K 0.01% 706
2023
Q2
$13K Sell
500
-19,500
-98% -$473K ﹤0.01% 1179
2023
Q1
$446K Buy
+20,000
New +$483K 0.03% 436
2022
Q4
Sell
-14,200
Closed -$236K 1858
2022
Q3
$236K Buy
+14,200
New +$320K 0.02% 577
2022
Q1
Sell
-200
Closed -$8K 1562
2021
Q4
$8K Buy
+200
New +$8.84K 0.02% 855

Other funds holding VCYT

Aquatic Capital Management's VCYT Position: Q1 2026 in Review

Aquatic Capital Management increased its Veracyte (VCYT) stake by 278% in Q1 2026, buying an estimated $1.08M and bringing the position to 39,535 shares worth $1.27M. The position accounts for 0.04% of the portfolio, ranked #508.

Aquatic Capital Management first reported a position in VCYT in Q4 2021 and has held it in 11 quarters since. The position peaked at $1.32M in Q3 2024. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Aquatic Capital Management held 39,535 shares of Veracyte worth $1.27M as of Q1 2026.
  • Aquatic Capital Management bought 29,080 Veracyte shares in Q1 2026, an estimated $1.08M.
  • Veracyte made up 0.04% of Aquatic Capital Management's portfolio in Q1 2026, its #508 holding.
  • Aquatic Capital Management first reported a position in Veracyte in Q4 2021 and has held it in 11 quarters since.
  • Aquatic Capital Management's Veracyte position peaked at $1.32M in Q3 2024.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.